与此同时,该公司在周二收盘后表示,Idera 不再招募患者进入 tilsotolimod 与 BMS的 Yervoy 和 ...查看全文
$井寺制药(IDRA)$ S-8 - Securities to be offered to employees in employee benefit plans Filed: 2017-08-07 AccNo: 0001104659-17-049740 Size: 113 KB 网页链接
$井寺制药(IDRA)$ S-8 - Securities to be offered to employees in employee benefit plans Filed: 2017-08-07 AccNo: 0001104659-17-049739 Size: 138 KB 网页链接
$井寺制药(IDRA)$ 8-K - Current report Filed: 2017-06-09 AccNo: 0001104659-17-038412 Size: 132 KBItem 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain OfficersItem 5.07: Submission of...
$井寺制药(IDRA)$ 8-K - Current report Filed: 2017-05-23 AccNo: 0001104659-17-034361 Size: 5 MBItem 7.01: Regulation FD DisclosureItem 9.01: Financial Statements and Exhibits 网页链接
$井寺制药(IDRA)$ 8-K - Current report Filed: 2017-05-23 AccNo: 0001104659-17-034361 Size: 5 MBItem 7.01: Regulation FD DisclosureItem 9.01: Financial Statements and Exhibits 网页链接
$井寺制药(IDRA)$ 10-Q - Quarterly report [Sections 13 or 15(d)] Filed: 2017-05-04 AccNo: 0001558370-17-003522 Size: 3 MB 网页链接
$井寺制药(IDRA)$ S-8 - Securities to be offered to employees in employee benefit plans Filed: 2017-05-04 AccNo: 0001104659-17-029897 Size: 197 KB 网页链接
$井寺制药(IDRA)$ 内部交易: 2017-05-01,Director,Pillar Invest Corp ,卖出,450815普通股, $2.26
$井寺制药(IDRA)$ DEF 14A - Other definitive proxy statements Filed: 2017-04-28 AccNo: 0001047469-17-003068 Size: 1 MB 网页链接
$井寺制药(IDRA)$ 内部交易: 2017-04-25,Director,Pillar Invest Corp ,卖出,890593普通股, $2.29